A nevus is a benign (non-cancerous) growth or lesion on the skin that is usually present at birth or develops during childhood. Nevi, as they are commonly known, can range in size and shape, and can vary in color from light brown to black. They may be raised or flat, and may or may not have hair growing from them. Nevi are very common, and most people have at least one. While nevi are usually harmless, in some cases they can develop into skin cancer. In this article, we will explore the causes and treatments of nevi, and provide a comprehensive guide to understanding this skin condition.
A nevus is a benign growth or lesion on the skin that is usually present at birth or develops during childhood. They can range in size and shape, and can vary in color from light brown to black. They may be raised or flat, and may or may not have hair growing from them. Nevi are very common, and most people have at least one.
There are several types of nevi, each with its own characteristics. The most common type is the flat, brown nevus, also known as a “mole”. These are usually harmless and require no treatment. Other types of nevi include congenital nevi, which are present at birth; dysplastic nevi, which are larger than normal and may have an irregular shape; and Spitz nevi, which are raised and often have a pink or red color.
The exact cause of nevi is not known, but they are believed to be related to sun exposure and genetics. Sun exposure is thought to play a role because nevi are more common in people with fair skin, who are more likely to be exposed to ultraviolet (UV) radiation from the sun. Genetics may also play a role, as nevi tend to run in families.
In addition to sun exposure and genetics, there are other risk factors that can increase a person’s likelihood of developing nevi. These include: • Having a family history of nevi • Having a weakened immune system • Having a history of frequent sunburns • Being exposed to certain chemicals • Having a pre-existing skin condition
While most nevi are harmless, in some cases they can develop into skin cancer. This is more likely to occur in people with a large number of nevi, or if the nevi are dysplastic. It is important to have any suspicious looking nevi examined by a doctor, as early detection and treatment can reduce the risk of skin cancer.
The diagnosis of nevi is usually made by a physical examination. The doctor will look for any suspicious looking nevi and may also take a biopsy to confirm the diagnosis. In some cases, a dermatologist may also use a special type of imaging called dermoscopy to look more closely at the nevi.
Most nevi do not require treatment and can be left alone. However, if the nevi are suspicious looking or if they are causing discomfort, the doctor may recommend treatment. Treatment options include excision (surgical removal), cryotherapy (freezing), or laser therapy.
The best way to prevent nevi is to limit sun exposure. This can be done by wearing protective clothing, using sunscreen, and avoiding direct sun exposure during peak hours (10am-4pm). It is also important to have any suspicious looking nevi examined by a doctor, as early detection and treatment can reduce the risk of skin cancer.
Nevi are benign growths or lesions on the skin that are usually present at birth or develop during childhood. They can range in size and shape, and can vary in color from light brown to black.
1.
EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues
2.
Universal screening approach achieves a comparable detection rate of lung cancer
3.
GLP-1 drugs linked to dramatically lower death rates in colon cancer patients
4.
The response of bipolar patients to lithium may be predicted by ancestry.
5.
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
1.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
2.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
3.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
4.
Precision Supportive Oncology: Managing Immune Toxicity, Treatment-Related Critical Illness and Long-Term Quality of Life
5.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Understanding the Role of Screening in Cancer Prevention
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XII
5.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation